Interestingly, expression of DNMT1 is associated with poor survival in breast cancer, is overexpressed specifically within TNBC, induces cancer cell invasion and survival through hypermethylation of key tumor suppressors, and is considered an epigenetic target for therapeutic blocking (40). Here, DNMT1 is linked to breast carcinoma.